eth-zurich

The Alzheimer's Drug That Bets the Plaques Are a Symptom

An ETH Zurich team spent nearly twenty years tracing why Alzheimer's nerve cells run out of energy, and the answer points to a protein the amyloid-clearing drugs never touched.